Microbot Medical Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Selling, general & administrative | $8.5M | $5.0M | — | — | — |
| Research and development | $6.3M | $6.6M | $5.7M | $7.7M | $6.2M |
| Operating income | -$14.7M | -$11.6M | -$9.9M | -$13.3M | -$11.4M |
| Net income | -$13.1M | -$11.4M | -$10.7M | -$13.2M | -$11.3M |
| Balance Sheet | |||||
| Cash and equivalents | $3.9M | $3.1M | $2.5M | $2.4M | $13.5M |
| Current assets | $79.8M | $5.8M | $7.9M | $8.8M | $15.9M |
| Total assets | $81.5M | $6.0M | $8.3M | $9.5M | $16.8M |
| Current liabilities | $3.4M | $2.5M | $3.8M | $2.1M | $2.0M |
| Total liabilities | $4.0M | $2.5M | $3.8M | $2.2M | $2.4M |
| Stockholders' equity | $77.6M | $3.5M | $4.5M | $7.3M | $14.4M |
| Cash Flow Statement | |||||
| Cash from operations | -$13.0M | -$8.8M | -$8.5M | -$11.5M | -$9.4M |
| Depreciation and amortization | $47,000 | $91,000 | $106,000 | $102,000 | $76,000 |
| Stock-based compensation | $1.1M | $1.3M | $1.4M | $1.8M | $1.4M |
| Capital expenditure | $60,000 | $25,000 | $33,000 | $84,000 | $69,000 |
| Free cash flow | -$13.1M | -$8.9M | -$8.6M | -$11.6M | -$9.4M |
Shares outstanding 67.2M · Free float 95.5%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.